Export

EN
FR
Emicizumab
Essential medicine status
General description

INN
Emicizumab
ATC codes
Medicine type
Biological agent
EML status history
First added in 2025 (TRS 1064) for Haemophilia A
Wikipedia
DrugBank
Recommendations
Section
Medicines affecting coagulation
  • Parenteral > General injections > SC: 12 mg per 0.4 mL in vial; 30 mg per mL in mL vial; 60 mg per 0.4 mL in vial; 105 mg per 0.7 mL in vial; 150 mg per mL in vial; 300 mg per 2 mL in vial
Indications